Your browser doesn't support javascript.
loading
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.
Beatty, Gregory L; Haas, Andrew R; Maus, Marcela V; Torigian, Drew A; Soulen, Michael C; Plesa, Gabriela; Chew, Anne; Zhao, Yangbing; Levine, Bruce L; Albelda, Steven M; Kalos, Michael; June, Carl H.
Afiliação
  • Beatty GL; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Haas AR; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Maus MV; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Torigian DA; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Soulen MC; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Plesa G; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA.
  • Chew A; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA.
  • Zhao Y; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Levine BL; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA ; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Phil
  • Albelda SM; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kalos M; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • June CH; Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA ; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Phil
Cancer Immunol Res ; 2(2): 112-20, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24579088
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Pleurais / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Proteínas Ligadas por GPI / Neoplasias Pulmonares / Mesotelioma Limite: Aged / Aged80 / Humans / Male Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Panamá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Pleurais / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Proteínas Ligadas por GPI / Neoplasias Pulmonares / Mesotelioma Limite: Aged / Aged80 / Humans / Male Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Panamá